Diagnostic MicroRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle

Cancer Genomics and Proteomics

Volumn 10, Issue 3, 2013, Pages 93-113

  Ahmed, Farid E ^a,b   Ahmed, Nancy C ^b   Vos, Paul W ^c   Bonnerup, Chris ^d   Atkins, James N ^e   Casey, Michelle ^e   Nuovo, Gerard J ^f   Naziri, Wade ^g   Wiley, John E ^a   Mota, Helvecio ^a,h   Allison, Ron R ^a,i  

^a EAST CAROLINA UNIVERSITY   (United States)

^b GEM Tox Labs   (United States)

^c School of Allied Health   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e Southestern Medical Oncology Center   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g Department of Southern Surgical ^*  (United States)

^h CAROLINAS MEDICAL CENTER   (United States)

ⁱ 21ST CENTURY ONCOLOGY   (United States)

Author keywords

Bioinformatics; Colon cancer; Diagnosis; Gene expression; Histopathology; Microarrays; Mirna; QC; RNA; RT QPCR; Staging; Statistics; Stool samples

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 127; MICRORNA 134; MICRORNA 138; MICRORNA 143; MICRORNA 146A; MICRORNA 17; MICRORNA 183; MICRORNA 196A; MICRORNA 199A; MICRORNA 20A; MICRORNA 21; MICRORNA 214; MICRORNA 222; MICRORNA 29B; MICRORNA 7; MICRORNA 9; MICRORNA 92A; MICRORNA 938; MICRORNA 96; RNA 18S; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; COLON ADENOMA; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE MARKER; FECES ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; TUMOR INVASION;

EID: 84879391556     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. Davies RJ, Miller R and Coleman N: Colorectal cancer screening: Prospects for molecular stool analysis. Nature Rev Cancer 5: 199-209, 2005. (Pubitemid 40314951)
2. Peterson NB, Murff HJ, Ness RM and Dittus RS: Colorectal cancer screening among men and women in the United States. J Womens Health 16: 57-65, 2007.
3. Centers for Disease Control and Prevention: Increased use of colorectal cancer test: United States, 2002 and 2004. MMWR Mortal Weekly 55: 208-311, 2006.
4. Morikawa T, Kato J, Yamaji, Wada R, Miksushima T and Shiratori Y: Comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 125: 422-428, 2006.
5. Senore C, Ederle A, Fantin A, Andreoni B, Bisanti L, Grazzini G, Zappa M, Ferrero F, Maratti A, Giutiani O, Armadi P and Segnan N: Acceptability and side-effects of colonoscopy and sigmoido-scopy in a screening setting. J Med Screening 18: 128-134, 2011.
6. Bressler B, Paszat LF, Vinden C, Li C, He J and Rabeneck L: Colonoscopic miss rates for right-sided colon cancer: Population-based study. Gastroenterology 123: 452-456, 2004. (Pubitemid 39091893)
7. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut A I: Risk of perforation after colonoscopy and sigmoidoscopy: a population based study. J Natl Cancer Inst 95: 230-236, 2002.
8. Ahmed FE: The role of microRNA in carcinogenesis and biomarker selection: A methodological perspective. Exp Rev Mol Diag 7: 569-603, 2007. (Pubitemid 47547724)
9. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC III, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S and Shuber A: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5: 111-117, 2007. (Pubitemid 46096834)
10. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, Lamerz R and Kolligs FT: Analysis of promoter methylation in stool: A novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 3: 142-149, 2005. (Pubitemid 40220309)
11. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN and Shuber AP: Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel. Gastroenterology 119: 1219-1227, 2000.
12. Lees NP, Hrrison KL, Hall CN, Morgison GP and Povey AC: Human colorectal mucosal O6-alkylguanine DNAalkyltransfe- rase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents. Gut 56: 318-320, 2007.
13. Huang LH, Li LH, Yang F and Wang JF: Detection of aberrant methylation in fecal DNA s a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 13: 950-954, 2007. (Pubitemid 46470311)
14. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ Jr., Hamilton SR, Boynton K, Kinzler KW and Vogelstein B: Detection of APC mutations in fecal and DNA from patients with colorectal tumors. N Engl J Med 346: 311-320, 2002. (Pubitemid 34438838)
15. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA and Ross MA: Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. New Eng J Med 351: 2704-2714, 2004. (Pubitemid 39665324)
16. Ahmed FE: Liquid chromatography-mass spectrometry: A tool for proteome analysis and biomarker discovery and validation. Exp Opin Mol Diag 3: 429-444, 2009.
17. Ahmed FE, Vos P, James S, Lysle DT, Allison RR, Flake G, Sinar DR, Naziri W, Marcuard SP and Pennington R: Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genom Proteom 4: 1-20, 2007. (Pubitemid 46426643)
18. Ahmed FE: Gene-gene, gene-environment and multiple interactions in colorectal cancer. J Env Sci Health C 24: 1-101, 2006.
19. Rifai N, Gillette MA and Carr SA: Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nature Biotechol 24: 971-983, 2006. (Pubitemid 44215392)
20. Ahmed FE (ed.) Detection of Genetically Modified Organisms in Food. Howarth Press, Binghamton, NY, 325 pp, 2004.
21. Smith A, Young GP, Cole SR and Bampton P: Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107: 2152-2159, 2006. (Pubitemid 44665648)
22. Mandel JS: Screening for colorectal cancer. Gastroenterol Clin N Am 37: 97-115, 2008. (Pubitemid 351289026)
23. Rex D: Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 101: 2866-2877, 2006. (Pubitemid 44902662)
24. Ahmed FE and Vos P: Molecular markers for human colon cancer in stool and blood identified by RT-PCR. Anticancer Res 24: 4127-4134, 2004. (Pubitemid 40468718)
25. Ransohoff DF: Bias as a threat to the validity of cancer molecular marker research. Nature Rev Cancer 5: 142-149, 2005. (Pubitemid 40215862)
26. Nuovo GJ (ed.): In Situ Molecular Pathology and Co- Expression Analyses. Elsevier Science & Technology Books, Academic Press, 289 pp, 2012.
27. Deschner EE: Early proliferative changes in gastrointestinal neoplasia. Am J Gastroenterol 77: 207-211, 1982. (Pubitemid 12156025)
28. Correa A and Mungenast A: A comparison of current LCM equipment. Methods Enzymol 356: 3-12, 2002.
29. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta A: Laser capture microdissection. Science 274: 998-1001, 1996. (Pubitemid 26398425)
30. Walch A, Specht K, Smida A, Aubele, M, Zitzelsberger H, Hofler H and Werner M: Tissue microdissection techniques in qualitative genome and gene expression analysis. Histochem Cell Biol 115: 269-276, 2001. (Pubitemid 32323882)
31. Ahmed FE: Laser microdissection: application to carcinogenesis. Cancer Genom Proteom 3: 217-226, 2006.
32. Fleige S and Pfaffl M W: RNA integrity and the effect on the real-time qRT-PCR performance. Molec Aspects Med 27: 126- 139, 2006.
33. Willis MS, Fuda FS and Chenault CB: Current methods of colorectal cancer screening. Med Lab Obs 34: 12-19, 2002.
34. Liu CG, Callin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupos S, Dono M, Alder H, Bullrich F, Negrini M and Croce CM: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-9744, 2004. (Pubitemid 38869306)
35. Ahmed FE: Microarray RNA transcriptional profiling: Part II. Analytical considerations and annotations. Exp Rev Mol Diag 6: 736-750, 2006.
36. Huber W, von Heydebreck A, Sultmann M, Poustka A and Vingron M: Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18: S96-S104, 2002. (Pubitemid 41185642)
37. Draghici S: Data Analysis Tools for DNA Mcroarrays. Boca Raton, FL, Chapman/CRC, 2003.
38. Pavlidis P: Using ANOVA for gene selection from microarray studies of the nervous system. Methods 31: 282-289, 2003. (Pubitemid 37338765)
39. Benjamini Y and Hochberger Y: Controlling false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300, 1995.
40. Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Sinar DR, Naziri W and Marcuard SP: Diagnostic microRNA markers for screening sporadic human colon cancer and ulcerative colitis in stool and tissue. Cancer Genom Proteom 6: 281-296, 2009.
41. Ahmed FE, Vos PW, Jeffries C, Wiley J, Weidner DA, Mota H, Bonnerup C, Sibata C and Allison RR: Differences in mRNA and microRNA expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensitymodulated radiation therapy (IMRT), or conventional radiation therapy (RT). Cancer Genom Proteom 6: 109-128, 2009.
42. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ and Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
43. Morrison TB, Weis JJ and Wittwer, CT: Quantitation of low copy transcripts by continuous SYBR Green I monitoring during amplification. BioTechniques 24: 954-959, 1998.
44. Singer M and Berg P: Determining the number of copies of a DNA sequence in a gene. In: Genes and Genomes: A Changing Perspective, pp. 396-400. University Science Books, Mill Valley, California, 1991.
45. Wong ML and Medrano JF: Real-time RT-PCR for mRNA quantitation. BioTechniques 39: 1-11, 2005.
46. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM and Ruvkun G (2004) Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci USA 101: 360-365. (Pubitemid 38084255)
47. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS and Chen C: Real-time PCR quantification of precursor and mature microRNA. Methods 44: 31-38, 2008. (Pubitemid 350297984)
48. Ahmed FE (2000) Molecular markers for early cancer detection. J Env Sci Health C 18: 75-126.
49. Bernard PS and Wittwer CT: Homogenous amplification and variant detection by fluorescent hybridization probes. Clin Chem 46: 147-148, 2000. (Pubitemid 30104235)
50. Zhang C: Comparison of different quantitative PCR procedures in the analysis of the 4977-bp deletion in human mitochondrial DNA. Biochem Biophys Res Commun 223: 450-455, 1996. (Pubitemid 26245588)
51. Haberhausen, G, Pinsl, J, Kuhn C-C and Markert-Hahn C: Comparative study of different standardization concepts in quantitative competitive reverse transcription PCR assays. J Clin Microbiol 36: 628-633, 1998. (Pubitemid 28093239)
52. Bustin SA (ed.) A-Z of Quantitative PCR. International University Line, La Jolla, CA, 2004.
53. Ahmed FE, Vos P, James S, Lysle DT, Allison RR, Flake G, Sinar DR, Naziri W, Marcuard SP and Pennington R: Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genom Proteom 4: 1-20, 2007. (Pubitemid 46426643)
54. Ahmed FE, Vos PW, IJames S, Flake G, Sinar DR, Naziri W and Marcuard SP: Standardization for transcriptomic molecular markers to screen human colon cancer. Cancer Genom Proteom 4: 419-432, 2007.
55. Kaufman PB, Wu W, Kim D and Cseke LJ: Analysis of gene expression by semiquantitative PCR. In: Molecular and Cellular Methods in Biology and Medicine, pp. 245-262. CRC Press, Boca Raton, Fl, 1995.
56. Davidson LA, Lupton JR, Miskovsky E, Fields AP and Chapkin RS: Quantification of human intestinal gene expression profiling using exfoliated colonocytes: a pilot study. Biomarkers 8: 51-61, 2003. (Pubitemid 36109105)
57. Lee EJ and Schmittgen TD: Comparison of RNA assay methods used to normalize cDNA for quantitative real-time PCR. Anal Biochem 357: 299-301, 2006. (Pubitemid 44415685)
58. Lanza G, Ferracin M, Gafa R, Veronese R, Spizzo R, Pichiorri F, Liu C, Calin GA, Croce CM and Negrini M: mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54, 2007.
59. Tellman G: The E-method: A highly accurate technique for gene-expression analysis. Nat Meth 3: 1-2, 2006.
60. LightCycler Software®, Version 3.5, Roche Molecular Biochemicals, Mannheim, Germany, pp. 64-79, 2001.
61. Luu-The V, Paquet N, Calvo E and Cumps J: Improved realtime RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 38: 287-293, 2005. (Pubitemid 40216386)
62. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
63. Pfaffl M W: Quantification strategies in real-time PCR. In: A-Z of Quantitative PCR. Bustin SA (ed.). La Jolla, CA, USA, International University Line, pp. 89-120, 2004.
64. Tichopad A, Dilger M, Schwarz G and Pfaffl MW: Standardised determination of real-time PCR efficiency from a single reaction setup. Nucleic Acids Res 31: 21-33, 2003.
65. Bustin SA and Nolan T: Data analysis and interpretation. In: AZ of Quantitative PCR. Bustin S A (Ed), International University Line, La Jolla, CA, USA, pp. 439-492, 2004.
66. Vandesompele J, De Preter K, Pattyn F, Poppe B, Roy N V, Paepe AD and Spdema F: Accurate normalization of real-time quantitative RT-PCR by geometric average of multiple internal control genes. Genome Biology 3: 7, 2010.
67. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesomplete J and Wittwer CT: The MIQUE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622, 2009.
68. Koss LG and Melamed MR (eds.) Koss' Diagnostic Cytology and Histopathologic Bases, 5th edition, Lippincott, Williams & Wilkins, New York, NY, 2005.
69. Petrelli NJ, Letourneau R, Weber T, Nava ME and Rodriguez-Bigas M: Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma. J Surg Oncol 71: 46-49, 1999. (Pubitemid 29244910)
70. Winter MJ, Nagtegaal ID, van Krieken JH and Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163: 2139-2148, 2003. (Pubitemid 37466457)
71. Matsushita HM, Matsumura Y, Moriya Y, Akasu T, Fujita S, Yamamoto S, Onouchi S, Saito A, Sugito M, Ito M, Kozu T, Minowa T, Momura S, Tsunoda H and Kakizoe T: A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology 129: 1918-1927, 2005. (Pubitemid 41772969)
72. Wegman E: Hypothetical data analysis using parallel coordinates. J Am Stat Assoc 85: 644-675, 1990.
73. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-789, 2003.
74. Riedmaier I, Bergmaier M, and Pfaffl MW: Comparison of two available platforms for determination of RNA quality. Biotechnol Biotechnol Eq 24: 2154-2159, 2010.
75. Pnaro NJ, Yuen PK, Sakazume T, Fortina P, Kricka LJ and Wilding P: Evaluation of DNA target sizing and quantification by the Agilent 2100 Bioanalyzer. Clin Chem 46: 1851-1853, 2000.
76. Di Cello F, Xie Y, Paul-Satyaseela M, and Kim KS: Approaches to bacterial RNA isolation and purification for microarray analysis of Escherichia coli K1 interaction with human brain microvascular endothelial cells. J Clin Microbiol 43: 4197- 4199, 2005. (Pubitemid 41129725)
77. Ahmed FE, James S I, Lysle DT, Dobbs LJ Jr., Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ and Allison RR: Improved methods for extracting RNA from exfoliated human colonocytes from stool and RT-PCR analysis. Dig Dis Sci 49: 2650-2659, 2004.
78. Kohler BA, Ward E, McCarthy BJ et al: Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 999: 999-999, 2011.
79. Li J N, Zhao L, Wu J, Wu B, Yang H, Zhang HH and Qian JM: Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer. J Dig Dis 13: 24-32, 2012.
80. Cheng L, Eng G, Nieman LZ, Kapadia AS and Du XL: Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 34: 573-580, 2011.
81. Wu X, Chen VW, Martin J et al: Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1955 to 1999. Cancer Epidemiol Biomarkers Prev 13: 1215-1222, 2004. (Pubitemid 38917911)
82. Green J, Watson J, Roche M, Beral V and Patnick J: Stage, grade and morphology of tumors of the colon and rectum recorded in the Oxford Cancer Registry, 1995-2003. Br J Cancer 96: 140-142, 2007. (Pubitemid 46094652)
83. Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ and Sherr DL: Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 116: 4354-4359, 2010.
84. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L and Pierotti MA: Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 10: 4015-4021, 2004. (Pubitemid 38812476)
85. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA and Orntoft TF (2003) Differential gene expression in colon cancer of the ceacum versus the sigmoid and rectosigmoid. Gut 54: 374-384.
86. Lindblom A: Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13: 63-69, 2001. (Pubitemid 32060047)
87. Konishi K, Fujii T, Boku N, Kato S, Koba I, Ohtsu A, Tajiri H, Ochiai A and Yoshida S: Clinicopathological differences between colonic and rectal carcinoma: are they based on the same mechanisms of carcinogenesis. Gut 45: 818-821, 1999.
88. Gervaz P, Bouzourene H and Gerottini JP: Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor locations. Dis Colon Rectum 44: 364-372, 2001.
89. Minoo P, Zlobec I, Peterson M, Terracciano L and Lugli A: Characterization of rectal, proximal and distal colon cancer based on clinicopathological, molecular and protein profiles. Int J Oncol 37: 707-718, 2010.
90. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ and Samowitz W: A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 52: 1304-1311, 2009.
91. He QJ, Zeng WF and Sham JS: Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 144: 112-118, 2003. (Pubitemid 36808957)
92. Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G and Bukholm RK: Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas. Gastroenterol Res Pract 29: 785-830, 2009.
93. Kozomara A and Griffiths-Jones S: miRBase: Integrating microRNA annotation and deep-sequencing data. Nucl Acids Res 39(Suppl 1): D152-D157, 2011.
94. Reinhart BJ, Slack FJ, Basson M, Pasquinell AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G: RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000. (Pubitemid 30130993)
95. Xu P, Guo M and Hay BA: MicroRNAs and the regulation of cell death. Trend Genet 20: 617-624, 2004. (Pubitemid 39441280)
96. Gregory RI and Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512, 2005. (Pubitemid 40616320)
97. Cummins JM and Velculescu VE: Implication of microRNA profiling for cancer diagnosis. Oncogene 15: 6220-6227, 2006. (Pubitemid 44527853)
98. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner M, Frankel WL, Morgan DL, Positer RG, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Neaci T, Calin GA, Querzoli P, Negrini M and Croce CM: Expression profiling identifies distinct microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007. (Pubitemid 46214304)
99. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamota A, Yokota J, Tanaka T, Galin GA, Liu CG, Groce CM and Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
100. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Margri E, Pedriali M and Fabbri M: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
101. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Benturch Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Kinzler KW, Juhl H, Vogelstein B and Velculescu VE: The colorectal microRNome. Proc Natl Acad Sci USA 103: 3687-3692, 2006.
102. Calin GA, Ferracin M, Cimmino A, Dileva G, Shimiz M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Ludiano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Adler H, Volinia S, Liu CG, Kipps TJ, Negrini M and Croce CM: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Eng J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
103. Eis PS, TamW, Sun L, ChadburnA, Li Z, Gomez MF, Lund E and Dahlberg JE: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc NatlAcad Sci USA 102: 3627-3632, 2003.
104. Chang-Zheng C: MicroRNAs as oncogenes and tumor supressors. N Eng J Med 353: 1768-1771, 2005.
105. Calin GA, Sevignai C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004. (Pubitemid 38327724)
106. Schepler T, Reinert JT, Oslenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Orntoft T and Andersen CL: Diagnostic and prognostic microRNAs in Stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
107. Barbarotto E, Schmittgen TD and Calin GA: MicroRNAs and cancer: Profile, profile, profile. Int J Cancer 122: 969-977, 2008. (Pubitemid 351213993)
108. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TS, Kwong DLW, Au GKH, Liu CG, Calin GA and Harris CC: MicroRNA expression profile associated with progression and therapeutic outcome in colon adenocarcinoma. J Am Med Assoc 299: 425-436, 2008. (Pubitemid 351185951)
109. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
110. Osborn NK and Ahlquist DA: Stool screening for colorectal cancer: Molecular approaches. Gastroenterology 128: 192-206, 2005. (Pubitemid 40039970)
111. Nair P, Lagerhola S, zdutta S, Shami S, Davis K, Ma S and Malayeri M: On the nature of cellular elements for stool in the pathophysiology of colonic diseases. J Clin Gastroentrol 36(Suppl 1): S44-S39, 2003.
112. Davidson LA, Lupton JR, Miskovsky E, Fields AP and Chapkin RS: 2003 Quantification of human intestinal gene expression profiling using exfoliated colonocytes: A pilot study. Biomarkers 8: 51-61, 2003. (Pubitemid 36109105)
113. Singer M and Berg P: Determining the number of copies of a DNA sequence in a gene. In: Genes and Genomes: A Changing Perspective, University Science Books, Mill Valley, California, pp. 396-400, 1991.
114. Wong ML and Medrano JF: Real-time RT-PCR for mRNA quantitation. BioTechniques 39: 1-11, 2005.
115. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS and Chen C: Real-time PCR quantification of precursor and mature microRNA. Methods 44: 31-38, 2008. (Pubitemid 350297984)
116. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL and Waas ET: Normalization of gene expression measurements in tumor tissues: Comparison of 13 endogenous control genes. Lab Invest 85: 154-159, 2005. (Pubitemid 40128049)
117. Thellin O, ZorziW, Lakaye B, De Borman B, Coumans B, Hensen G, Grisan T, Igout A and Heines E: Housekeeping genes as internal standards: Use and limits. J Biotechnol 76: 291-296, 1999.
118. Bargaje R, Hariharen M, Scaria V and Pillai B: Consensus miRNA expression profiles derived from interplatform normalization of microarray data. RNA 16: 16-25, 2010.
119. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and Tewari M: Circulating microRNAs as stable bloodbased markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
120. Volinia S, Calin GA, ZLiu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Lorio M, Roldo C, Ferracin M, Prucitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC and Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
121. Aandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M and Garcia-Foncillas J: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumor tissues. Mol Cancer 5: 29, 2006.
122. Jiang J, Lee EJ, Gusev Y and Schmittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005. (Pubitemid 41548806)
123. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang I, Jiang X, XiangY, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Ning G, Wang J, Zen K, Zhang J and Zhang CY: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
124. Shi B, Stepp-Lorenzino L, Prisco M, Linsley P, deAngelis T and Baserga R: MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590, 2007. (Pubitemid 350159311)
125. Guo C, Sah JF, Beard L, Willson JKV, Markowitz SD and Guda K: The noncoding RNA miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946, 2008.
126. Akao Y, Nakagawa Y and Naoe T: Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906, 2006.
127. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
128. Slaby O, Svoboda M, Fabian P, Serdova T, Knoflickova D, Bednarikova M, Nenatil R and Vyzala R: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
129. DeMuth JP, Jackson CM, Weaver DA, Crawford EL, Durzinsky DS, Durham SJ, Zaher A, Phillips ER, Khuder SA and Willey JC: The gene expression index MYC X E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells. Am J Respir Cell Mol Biol 19: 18-29, 1998.
130. Ngan CY, Yamamoto H, Seshimo I, Ezumi K, Terayama M, Hemmi H, Takemasa I, Ikeda M, Sekimoto M and Monden M: A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J Surg Oncol 95: 652-662, 2007. (Pubitemid 46954811)
131. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocol 4: 44-57, 2009.
132. Simpson RJ, Lim JE, Moritz RL and Mathivanan S: Exosomes: Proteomic insights and diagnostic potential. Exp Rev Proteomics 6: 267-283, 2009.